[1]
|
邬昊, 吕青. 全球及中国乳腺癌的流行病学趋势及防控启示: 2018-2022年《全球癌症统计报告》解读[J]. 中国普外基础与临床杂志 ,2024, 31(7): 796-802.
|
[2]
|
尹希, 牛建, 史海水. 三叶因子3的中枢功能研究进展[J]. 中国药物依赖性杂志, 2013, 22(6): 408-411.
|
[3]
|
Riemer, J., Bulleid, N. and Herrmann, J.M. (2009) Disulfide Formation in the ER and Mitochondria: Two Solutions to a Common Process. Science, 324, 1284-1287. https://doi.org/10.1126/science.1170653
|
[4]
|
昝香怡. 基于自然人群的横断面队列在胃癌高风险地区用血清标志物筛查胃癌及癌前病变的效能探讨[D]: [博士学位论文]. 兰州: 兰州大学临床医学, 2022.
|
[5]
|
Babyatsky, M., deBeaumont, M., Thim, L. and Podolsky, D. (1996) Oral Trefoil Peptides Protect against Ethanol-and Indomethacin-Induced Gastric Injury in Rats. Gastroenterology, 110, 489-497. https://doi.org/10.1053/gast.1996.v110.pm8566596
|
[6]
|
Pera, M., Heppell, J., Poulsom, R., Teixeira, F.V. and Williams, J. (2001) Ulcer Associated Cell Lineage Glands Expressing Trefoil Peptide Genes Are Induced by Chronic Ulceration in Ileal Pouch Mucosa. Gut, 48, 792-796. https://doi.org/10.1136/gut.48.6.792
|
[7]
|
Ge, Y., Zhang, J., Cao, J., Wu, Q., Sun, L., Guo, L., et al. (2012) TFF1 Inhibits Proliferation and Induces Apoptosis of Gastric Cancer Cells in Vitro. Bosnian Journal of Basic Medical Sciences, 12, 74-81. https://doi.org/10.17305/bjbms.2012.2499
|
[8]
|
Bossenmeyer-Pourié, C., Kannan, R., Ribieras, S., Wendling, C., Stoll, I., Thim, L., et al. (2002) The Trefoil Factor 1 Participates in Gastrointestinal Cell Differentiation by Delaying G1-S Phase Transition and Reducing Apoptosis. The Journal of Cell Biology, 157, 761-770. https://doi.org/10.1083/jcb200108056
|
[9]
|
Ebert, M.P.A., Hoffmann, J., Haeckel, C., Rutkowski, K., Schmid, R.M., Wagner, M., et al. (1999) Induction of TFF1 Gene Expression in Pancreas Overexpressing Transforming Growth Factor Alpha. Gut, 45, 105-111. https://doi.org/10.1136/gut.45.1.105
|
[10]
|
Jørgensen, K.H., Thim, L. and Jacobsen, H.E. (1982) Pancreatic Spasmolytic Polypeptide (PSP): I. Preparation and Initial Chemical Characterization of a New Polypeptide from Porcine Pancreas. Regulatory Peptides, 3, 207-219. https://doi.org/10.1016/0167-0115(82)90126-4
|
[11]
|
Jørgensen, K.D., Diamant, B., Jørgensen, K.H. and Thim, L. (1982) Pancreatic Spasmolytic Polypeptide (PSP): III. Pharmacology of a New Porcine Pancreatic Polypeptide with Spasmolytic and Gastric Acid Secretion Inhibitory Effects. Regulatory Peptides, 3, 231-243. https://doi.org/10.1016/0167-0115(82)90128-8
|
[12]
|
Hoffmann, W. (2015) TFF2, a MUC6-Binding Lectin Stabilizing the Gastric Mucus Barrier and More (Review). International Journal of Oncology, 47, 806-816. https://doi.org/10.3892/ijo.2015.3090
|
[13]
|
Kouznetsova, I., Kalinski, T., Meyer, F. and Hoffmann, W. (2011) Self-Renewal of the Human Gastric Epithelium: New Insights from Expression Profiling Using Laser Microdissection. Molecular BioSystems, 7, 1105-1112. https://doi.org/10.1039/c0mb00233j
|
[14]
|
Quante, M., Marrache, F., Goldenring, J.R. and Wang, T.C. (2010) TFF2 mRNA Transcript Expression Marks a Gland Progenitor Cell of the Gastric Oxyntic Mucosa. Gastroenterology, 139, 2018-2027.e2. https://doi.org/10.1053/j.gastro.2010.08.003
|
[15]
|
Jeffrey, G.P., Oates, P.S., Wang, T.C., Babyatsky, M.W. and Brand, S.J. (1994) Spasmolytic Polypeptide: A Trefoil Peptide Secreted by Rat Gastric Mucous Cells. Gastroenterology, 106, 336-345. https://doi.org/10.1016/0016-5085(94)90590-8
|
[16]
|
Hanisch, F., Bonar, D., Schloerer, N. and Schroten, H. (2014) Human Trefoil Factor 2 Is a Lectin That Binds α-Glcnac-Capped Mucin Glycans with Antibiotic Activity against Helicobacter Pylori. Journal of Biological Chemistry, 289, 27363-27375. https://doi.org/10.1074/jbc.m114.597757
|
[17]
|
Playford, R.J., Marchbank, T., Chinery, R., Evison, R., Pignatelli, M., Boulton, R.A., et al. (1995) Human Spasmolytic Polypeptide Is a Cytoprotective Agent That Stimulates Cell Migration. Gastroenterology, 108, 108-116. https://doi.org/10.1016/0016-5085(95)90014-4
|
[18]
|
Fujimoto, K., Fujii, G., Taguchi, K., Yasuda, K., Matsuo, Y., Hashiyama, A., et al. (2015) Involvement of Trefoil Factor Family 2 in the Enlargement of Intestinal Tumors in Apcmin/+ Mice. Biochemical and Biophysical Research Communications, 463, 859-863. https://doi.org/10.1016/j.bbrc.2015.06.025
|
[19]
|
Ortiz-Masiá, D., Hernández, C., Quintana, E., Veiázquez, M., Cebrián, S., Riaño, A., et al. (2009) Inos‐Derived Nitric Oxide Mediates the Increase in TFF2 Expression Associated with Gastric Damage: Role of HIF‐1. The FASEB Journal, 24, 136-145. https://doi.org/10.1096/fj.09-137489
|
[20]
|
Aikou, S., Ohmoto, Y., Gunji, T., Matsuhashi, N., Ohtsu, H., Miura, H., et al. (2011) Tests for Serum Levels of Trefoil Factor Family Proteins Can Improve Gastric Cancer Screening. Gastroenterology, 141, 837-845.e7. https://doi.org/10.1053/j.gastro.2011.05.040
|
[21]
|
Peterson, A.J., Menheniott, T.R., O’Connor, L., Walduck, A.K., Fox, J.G., Kawakami, K., et al. (2010) Helicobacter Pylori Infection Promotes Methylation and Silencing of Trefoil Factor 2, Leading to Gastric Tumor Development in Mice and Humans. Gastroenterology, 139, 2005-2017. https://doi.org/10.1053/j.gastro.2010.08.043
|
[22]
|
Muskett, F.W., May, F.E.B., Westley, B.R. and Feeney, J. (2003) Solution Structure of the Disulfide-Linked Dimer of Human Intestinal Trefoil Factor (TFF3): The Intermolecular Orientation and Interactions Are Markedly Different from Those of Other Dimeric Trefoil Proteins. Biochemistry, 42, 15139-15147. https://doi.org/10.1021/bi030182k
|
[23]
|
Jahan, R., Shah, A., Kisling, S.G., Macha, M.A., Thayer, S., Batra, S.K., et al. (2020) Odyssey of Trefoil Factors in Cancer: Diagnostic and Therapeutic Implications. Biochimica et Biophysica Acta (BBA)—Reviews on Cancer, 1873, Article ID: 188362. https://doi.org/10.1016/j.bbcan.2020.188362
|
[24]
|
Yang, Y., Lin, Z., Lin, Q., Bei, W. and Guo, J. (2022) Pathological and Therapeutic Roles of Bioactive Peptide Trefoil Factor 3 in Diverse Diseases: Recent Progress and Perspective. Cell Death & Disease, 13, Article No. 62. https://doi.org/10.1038/s41419-022-04504-6
|
[25]
|
Chan, M.W.Y., Chan, V.Y.W., Leung, W.K., Chan, K.K., To, K.F., Sung, J.J.Y., et al. (2005) Anti-Sense Trefoil Factor Family-3 (intestinal Trefoil Factor) Inhibits Cell Growth and Induces Chemosensitivity to Adriamycin in Human Gastric Cancer Cells. Life Sciences, 76, 2581-2592. https://doi.org/10.1016/j.lfs.2004.11.014
|
[26]
|
Efstathiou, J.A., Noda, M., Rowan, A., Dixon, C., Chinery, R., Jawhari, A., et al. (1998) Intestinal Trefoil Factor Controls the Expression of the Adenomatous Polyposis Coli-Catenin and the E-Cadherin-Catenin Complexes in Human Colon Carcinoma Cells. Proceedings of the National Academy of Sciences of the United States of America, 95, 3122-3127. https://doi.org/10.1073/pnas.95.6.3122
|
[27]
|
Yio, X., Zhang, J., Babyatsky, M., Chen, A., Lin, J., Fan, Q., et al. (2005) Trefoil Factor Family-3 Is Associated with Aggressive Behavior of Colon Cancer Cells. Clinical & Experimental Metastasis, 22, 157-165. https://doi.org/10.1007/s10585-005-6615-z
|
[28]
|
Taupin, D.R., Kinoshita, K. and Podolsky, D.K. (2000) Intestinal Trefoil Factor Confers Colonic Epithelial Resistance to Apoptosis. Proceedings of the National Academy of Sciences of the United States of America, 97, 799-804. https://doi.org/10.1073/pnas.97.2.799
|
[29]
|
Chan, V.Y.W., Chan, M.W.Y., Leung, W., Leung, P., Sung, J.J.Y. and Chan, F.K.L. (2005) Intestinal Trefoil Factor Promotes Invasion in Non-Tumorigenic Rat-2 Fibroblast Cell. Regulatory Peptides, 127, 87-94. https://doi.org/10.1016/j.regpep.2004.10.016
|
[30]
|
Dhar, D.K., Wang, T.C., Tabara, H., Tonomoto, Y., Maruyama, R., Tachibana, M., et al. (2005) Expression of Trefoil Factor Family Members Correlates with Patient Prognosis and Neoangiogenesis. Clinical Cancer Research, 11, 6472-6478. https://doi.org/10.1158/1078-0432.ccr-05-0671
|
[31]
|
Rodrigues, S., Aken, E., Bocxlaer, S., Attoub, S., Nguyen, Q., Bruyneel, E., et al. (2003) Trefoil Peptides as Proangiogenic Factors in Vivo and in Vitro: Implication of Cyclooxygenase‐2 and EGF Receptor Signaling. The FASEB Journal, 17, 7-16. https://doi.org/10.1096/fj.02-0201com
|
[32]
|
Im, S., Yoo, C., Jung, J., Choi, H.J., Yoo, J. and Kang, C.S. (2013) Reduced Expression of TFF1 and Increased Expression of TFF3 in Gastric Cancer: Correlation with Clinicopathological Parameters and Prognosis. International Journal of Medical Sciences, 10, 133-140. https://doi.org/10.7150/ijms.5500
|
[33]
|
Emami, S., Rodrigues, S., Rodrigue, C.M., Le Floch, N., Rivat, C., Attoub, S., et al. (2004) Trefoil Factor Family (TFF) Peptides and Cancer Progression. Peptides, 25, 885-898. https://doi.org/10.1016/j.peptides.2003.10.019
|
[34]
|
Guleng, B., Han, J., Yang, J., Huang, Q., Huang, J., Yang, X., et al. (2011) TFF3 Mediated Induction of VEGF via Hypoxia in Human Gastric Cancer SGC-7901 Cells. Molecular Biology Reports, 39, 4127-4134. https://doi.org/10.1007/s11033-011-1195-2
|
[35]
|
Christine, R., Sylvie, R., Erik, B., Geneviève, P., Amélie, R., Gérard, R., et al. (2005) Implication of STAT3 Signaling in Human Colonic Cancer Cells during Intestinal Trefoil Factor 3 (TFF3)—And Vascular Endothelial Growth Factor-Mediated Cellular Invasion and Tumor Growth. Cancer Research, 65, 195-202. https://doi.org/10.1158/0008-5472.195.65.1
|
[36]
|
Li, Y., Sun, Z., Liu, K., Qiu, W., Yao, R., Feng, T., et al. (2014) Prognostic Significance of the Co-Expression of Nucleophosmin and Trefoil Factor 3 in Postoperative Gastric Cancer Patients. Molecular and Clinical Oncology, 2, 1055-1061. https://doi.org/10.3892/mco.2014.351
|